ECPPA: Randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women

ECPPA: Randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women

Dades bibliogràfiques
Autors principals:	Atallah, A, Collins, R, Farrell, B, Handoll, H, Freitas, A, Kinsui, L, Fukushima, O, Amorim, M, Eduardo, R, Durante, A, Vieira, C, Filho, J, Davolos, L, Zambotti, R, Negrao, C, Alves, O, Tobias, P, Freire, C, Almeida, C, Neto, J, Bertechini, L, Maest, I, Peracoli, J, Rudge, M, Silva, I
Format:	Journal article
Publicat:	1996

Ítems similars

LOW-DOSE ASPIRIN IN PREGNANCY AND EARLY-CHILDHOOD DEVELOPMENT - FOLLOW-UP OF THE COLLABORATIVE LOW-DOSE ASPIRIN STUDY IN PREGNANCY
per: Farrell, B, et al.
Publicat: (1995)

Aspirin in the primary prevention of vascular disease Reply
per: Baigent, C, et al.
Publicat: (2009)

Aspirin in the primary prevention of vascular disease Reply
per: Baigent, C, et al.
Publicat: (2009)

Aspirin and stroke.
per: Buring, J, et al.
Publicat: (1990)

Aspirin in ischemic heart disease.
per: Hennekens, C, et al.
Publicat: (1992)

Low-dose aspirin for the prevention of atherothrombosis.
per: Patrono, C, et al.
Publicat: (2005)

Benefit of heparin plus aspirin vs aspirin alone in unstable angina.
per: Collins, R, et al.
Publicat: (1996)

Low-dose aspirin for migraine prophylaxis.
per: Buring, J, et al.
Publicat: (1990)

Drug therapy - Low-dose aspirin for the prevention of atherothrombosis
per: Patrono, C, et al.
Publicat: (2005)

ASPIRIN USE AND CHRONIC DISEASES
per: Hennekens, C, et al.
Publicat: (1990)

Aspirin and transient ischaemic attacks.
per: Peto, R, et al.
Publicat: (1979)

Immediate aspirin for suspected ischaemic stroke.
per: Baigent, C, et al.
Publicat: (1999)

TRUE RESISTANCE AND PSEUDORESISTANCE TO ASPIRIN
per: A. I. Martynov, et al.
Publicat: (2015-09-01)

TRUE RESISTANCE AND PSEUDORESISTANCE TO ASPIRIN
per: A. I. Martynov, et al.
Publicat: (2015-09-01)

Aspirin plus calcium supplementation to prevent superimposed preeclampsia: a randomized trial
per: E.V. Souza, et al.
Publicat: (2014-05-01)

Aspirin, salicylates and cancer
per: Morgan, G, et al.
Publicat: (2011)

An overview of the British and American aspirin studies.
per: Hennekens, C, et al.
Publicat: (1988)

Aspirin for primary prevention of vascular disease in people with diabetes.
per: Haynes, R, et al.
Publicat: (2009)

Preliminary evidence of a high risk of bleeding on aspirin plus clopidogrel in aspirin-naive patients in the acute phase after TIA or minor ischaemic stroke.
per: Geraghty, O, et al.
Publicat: (2010)

Regular use of aspirin and pancreatic cancer risk
per: Mahoney Martin C, et al.
Publicat: (2002-09-01)

Hydroxycarbamide plus Aspirin vs Aspirin alone in patients with essential Thrombocythaemia aged 40-59 years without high-risk features
per: Buck, G, et al.
Publicat: (2018)

Effects of aspirin for primary prevention in persons with diabetes mellitus
per: Bowman, L, et al.
Publicat: (2018)

Clopidogrel used in combination with aspirin compared with aspirin alone in the treatment of non-ST-segment-elevation acute coronary syndromes: a systematic review and economic evaluation
per: C Main, et al.
Publicat: (2004-10-01)

Warfarin versus aspirin for stroke prevention (BAFTA) - Reply
per: Mant, J, et al.
Publicat: (2007)

Effect of maternal hydration on the increase of amniotic fluid index
per: V.T.M. Borges, et al.
Publicat: (2011-03-01)

Effect of maternal hydration on the increase of amniotic fluid index
per: V.T.M. Borges, et al.
Publicat: (2011-03-01)

Effect of Aspirin on Cell Growth of Human MG-63 Osteosarcoma Line
per: E. De Luna-Bertos, et al.
Publicat: (2012-01-01)

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.
per: Baigent, C, et al.
Publicat: (2009)

Benefit of aspirin plus angiotensin-converting enzyme inhibitor.
per: Baigent, C, et al.
Publicat: (2001)

Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomised trial for the prevention of pre-eclampsia and its complications.
per: Rotchell, Y, et al.
Publicat: (1998)

Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.
per: Hennekens, C, et al.
Publicat: (1989)

Interaction of aspirin (acetylsalicylic acid) with lipid membranes.
per: Matthew A Barrett, et al.
Publicat: (2012-01-01)

The antithrombotic profile of aspirin. Aspirin resistance, or simply failure?
per: Muntaner Juan, et al.
Publicat: (2004-01-01)

Aspirin Induces Apoptosis through Release of Cytochrome c from Mitochondria
per: Katja C. Zimmermann, et al.
Publicat: (2000-01-01)

ASPIRIN AND THE STOMACH - REPLY
per: Doll, R, et al.
Publicat: (1981)

Aspirin-triggered DHA metabolites inhibit angiogenesis
per: M. Vara-Messler, et al.
Publicat: (2025-02-01)

ASCEND-Eye: effects of aspirin on diabetic retinopathy
per: Sammons, E, et al.
Publicat: (2024)

Antiplatelet therapy: aspirin for asymptomatic atherosclerosis?
per: Patrono, C, et al.
Publicat: (2010)

Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review.
per: Teo, K, et al.
Publicat: (2002)

Efficacy of aspirin in people with diabetes: an individual participant data meta-analysis of 26 randomised trials
per: Wong, C, et al.
Publicat: (2014)